Wednesday, 28 September, 2022

Topic: Sputnik

Sputnik V found to be less effective against Beta variant in lab tests, study says

Blood samples from recipients of both doses of Sputnik showed that the vaccine was 6 times less effective against the Beta variant in laboratory tests.

Mixing vaccines without evidence a ‘dangerous’ trend, WHO’s Soumya Swaminathan says

Swaminathan warned that it will be a chaotic situation in countries if citizens start deciding ‘when and who should be taking a second, third or fourth dose’.

Russian Direct Investment Fund, Panacea Biotec launch production of Sputnik V in India

The first batch produced at Panacea Biotec's facilities in Himachal Pradesh will be shipped to Russia for quality control. Full-scale production is expected to start this summer.

Amid vaccine shortage, Delhi govt writes to Dr Reddy’s Labs for 67 lakh Sputnik doses

Earlier Deputy Chief Minister Manish Sisodia claimed that Covaxin manufacturer Bharat Biotech has refused to provide additional doses to the national capital.

Dr Reddy’s administers first dose of Sputnik V vaccine in India

The imported doses of the Covid vaccine, which received regulatory clearance on 13 May, are presently priced at a maximum retail price of Rs 948, with 5% GST per dose.

Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod

Kirill Dmitriev, CEO of Russian Direct Investment Fund that makes Sputnik V, also says majority of vaccine doses will be manufactured in India.

Oversupply of Covid shot in Russia but skepticism dogs Sputnik V vaccine drive

Not many are taking the Sputnik V vaccine with the low numbers being blamed on Russians’ distrust of officialdom dating back to the Soviet era and doubts over the vaccine.

Pakistan close to granting approval to Russia’s Sputnik Covid vaccine

Pakistan has already ordered 1.2 million doses of Chinese Sinopharm vaccine, with deliveries to start 31 January. It has also given approval to AstraZeneca shot for private use.

‘No safety concerns’ — Dr Reddy’s seeks DCGI nod to continue Sputnik V phase 3 trials

No safety concerns identified during Sputnik V mid-stage trial, data has been submitted to Drugs Controller General of India for a review, Dr. Reddy’s says in a statement.

Russia’s Sputnik V vaccine has no peer-reviewed data yet. Question is — would you take it

Russia hasn’t released late-stage phase 3 data on its vaccine. That said, what we do know about Sputnik V and its design should give us some degree of confidence.

On Camera


Congress leader Rahul Gandhi and Yogendra Yadav at the Bharat Jodo Yatra | YogendraYadav/Facebook

‘Congress must die’, I said in 2019. What I meant then, and what’s changed now

At this juncture in history, you don't hold on to grudges. Following Paul Samuelson, I ask everyone: 'When the situation changes, I change my assessment. What about you, sir?'
European Commission President Ursula von der Leyen and EU Foreign Policy Chief Josep Borrell address the media on the Ukraine crisis in Brussels, Belgium, on 28 September 2022 | Yves Herman/Reuters

Oil price cap to blacklistings — EU slaps new ‘biting’ sanctions on Russia over Ukraine

Ursula von der Leyen, who proposed the fresh sanctions said the European Union is 'determined' to make Russia pay the price for the further escalation with Ukraine.


File image of Lieutenant General Anil Chauhan Twitter@adgpi

Centre appoints ‘China expert’ Lt Gen Anil Chauhan as new CDS

Lt Gen Chauhan retired as the Eastern Army Commander on 31 May, 2021. Prior to that, he was the Director General of Military Operations during the Balakot air strike in 2019.
Illustration by Soham Sen | ThePrint

AAP’s filling a big vacuum in Indian politics. Question is how long it can sustain without ideology

If you find admiration for AAP qualified, if not muted among many of the Modi-BJP’s critics, it is because they question it for its lack of ideological clarity. Especially on secularism.